ALPS Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-85,663
| Closed | -$1.15M | – | 907 |
|
|
2019
Q1 | $1.15M | Buy |
85,663
+3,707
| +5% | +$49.7K | 0.01% | 296 |
|
|
2018
Q4 | $762K | Buy |
81,956
+18,995
| +30% | +$177K | 0.01% | 364 |
|
|
2018
Q3 | $876K | Buy |
62,961
+11,871
| +23% | +$165K | 0.01% | 438 |
|
|
2018
Q2 | $808K | Buy |
51,090
+5,474
| +12% | +$86.6K | 0.01% | 394 |
|
|
2018
Q1 | $784K | Buy |
45,616
+13,558
| +42% | +$233K | 0.01% | 364 |
|
|
2017
Q4 | $703K | Buy |
32,058
+3,728
| +13% | +$81.8K | ﹤0.01% | 327 |
|
|
2017
Q3 | $1.16M | Buy |
28,330
+2,364
| +9% | +$96.7K | 0.01% | 230 |
|
|
2017
Q2 | $782K | Buy |
25,966
+1,498
| +6% | +$45.1K | 0.01% | 271 |
|
|
2017
Q1 | $885K | Sell |
24,468
-11,617
| -32% | -$420K | 0.01% | 229 |
|
|
2016
Q4 | $1.81M | Sell |
36,085
-8,718
| -19% | -$437K | 0.01% | 183 |
|
|
2016
Q3 | $2.35M | Sell |
44,803
-7,191
| -14% | -$378K | 0.02% | 174 |
|
|
2016
Q2 | $2.15M | Buy |
51,994
+38,705
| +291% | +$1.6M | 0.02% | 166 |
|
|
2016
Q1 | $540K | Buy |
+13,289
| New | +$540K | 0.01% | 208 |
|